Mutational activation of ras genes is required for the onset and maintenance of different malignancies. Here we show, using a combination of molecular physiology, nutritional perturbations and transcriptional profiling, that full penetrance of phenotypes related to oncogenic Ras activation, including the shift of carbon metabolism towards fermentation and upregulation of key cell cycle regulators, is dependent upon glucose availability. These responses are induced by Ras activation, being specifically reverted by downregulation of the Ras pathway obtained through the expression of a dominant-negative Rasspecific guanine nucleotide exchange protein. Our data allow to link directly to ras activation the alteration in energy metabolism of cancer cells, their fragility towards glucose shortage and ensuing apoptotic death.
Introduction
Ras proteins are small GTPases able to bind either GTP ('on' state) or GDP ('off' state), thus acting as intracellular molecular switches (Lowy and Willumsen, 1993) linking growth factor activation to the cell cycle machinery (Kerkhoff and Rapp, 1998; Roovers and Assoian, 2000) . The level of the active GTP-bound form results from the balance of the competing activity of GTPase-activating proteins (GAP) and guanine nucleotide exchange factors (GEF) (Feig, 1994; Reuther and Der, 2000) . Each Ras protein can work as an oncoprotein upon mutational activation (Rodenhuis, 1992; de Vries et al., 1996) . Oncogenic versions of Ras are found mostly in the GTP-bound form either because of reduced GTPase activity or because of increased GTP/GDP exchange (Grunicke and Maly, 1993; Scheffzek et al., 1997) .
Whereas transfection of primary cells with oncogenic K-ras brings up accelerated senescence and cell death (Serrano et al., 1997) , it induces transformation in immortalized lines, such as NIH3T3 mouse fibroblasts. Mutational and/or epigenetic modifications that prevent these cells to senesce and allow them to continue unrestricted cell proliferation are unable to sustain the expression of a transformed phenotype in the absence of an activated Ras pathway, indicating that activated signal-transduction plays a key role in alterations of cell physiology properties leading to the transformed phenotype. Indeed, a large number of studies suggests that six essential alterations in tumor cell physiology take place in mammalian tumors: cell sufficiency in growth signals, insensitivity to growth inhibitory signals, evasion from apoptosis, unlimited replicative potential, sustained angiogenesis and tissue invasion and metastasis (Hanahan and Weinberg, 2000) .
Activated ras genes have been found in about 25% of human tumors (Bos, 1995) . Various strategies for the downregulation of Ras pathway have been reported: treatment of antibodies to K-Ras (Cochet et al., 1999; Russell et al., 1999) , incorporation of a dominantnegative K-Ras mutant into target cells (Takeuchi et al., 2000) , expression of an antisense specific to K-ras (Monia et al., 1992; Kita et al., 1999) , retroviral delivery of a ribozyme (Kijima et al., 2004) , short interfering RNAs (Brummelkamp et al., 2002) and utilization of compounds able to block the Ras-Raf interaction (Kato-Stankiewicz et al., 2002) . We developed a genetically defined experimental system that allowed us to show that expression of a GEF dominant-negative mutant (that we call GEF-DN) downregulates Ras activity both in vitro (Vanoni et al., 1999) and in vivo on the basis of morphology, anchorage-independent growth and reduction of Ras-dependent tumor formation in nude mice (Bossu' et al., 2000) . In the light of results reported above, it is not surprising that an active search for molecules able to inhibit the Ras signaling pathway resulted in the development of several compounds currently used in clinical trials (Downward, 2003) .
Increasing attention has been given in recent years to the connection between metabolism and cancer. Under aerobic conditions, normal cells use oxidative phosphorylation as a predominant method for ATP generation. In sharp contrast to normal cells, a common feature to most solid tumors is a major use of glycolysis as ATP source (Warburg, 1956; Mathupala et al., 1997; Mazurek and Eigenbrodt, 2003; Ramanathan et al., 2005) . It has been proposed that the selection of the glycolytic phenotype in cancer cells may be owing to adaptation to hypoxia (Gatenby and Gillies, 2004; Rajendran et al., 2004) , a condition characterizing the slowly dividing cancer cells found in large portions of solid tumors not supported by a functional blood supply (Dang and Semenza, 1999; Robey et al., 2005) . Alternatively, the hypoxic adaptation and following glycolytic phenotype could depend on activation of oncogenes (i.e. ras), or loss of antioncogenes (reviewed by Dang and Semenza, 1999) .
To address specifically the role played by the Ras oncoprotein in the road to cancer and in the ability of transformed cells to adapt their energetic metabolism to altered growth conditions, in this report we make use of three cell lines: normal NIH3T3 mouse fibroblasts, NIH3T3 cells transformed by an activated form of the K-ras oncogene (Yamamoto and Perucho, 1984; Kahn et al., 1987) and K-ras-transformed NIH3T3 fibroblasts that stably overexpress the GEF-DN. We will refer to these cell lines as normal (NIH3T3), transformed (NIH3T3-K-Ras) and reverted (NIH3T3-K-Ras-expressing GEF-DN), respectively. We show that full penetrance of phenotypes related to oncogenic Ras activation, including the shift of carbon metabolism towards fermentation and upregulation of key cell cycle regulators, is dependent upon glucose availability. These responses are induced by Ras activation under normoxic conditions and are specifically reverted by downregulation of the Ras pathway obtained through the expression of the GEF-DN. Our data allow to link directly to ras activation the alteration in energy metabolism of cancer cells, their fragility towards glucose shortage and ensuing apoptotic death.
Results
Genome-wide transcriptional profiling of normal, transformed and reverted cell lines To analyse the effect of oncogenic ras on the gene profile of NIH3T3-transformed cells, a genome-wide transcriptional profiling was performed on normal, transformed and reverted cell lines during exponential growth with high glucose availability (48 h after plating) using Affymetrix Gene Chip technology. The MG_U74A-v2Array chip allows evaluating around 12 000 genes plus ESTs. Seven hundred and forty-eight of the interrogated genes and ESTs were found to be differentially expressed in at least one of the pair-wise comparison, that is, transformed vs normal, transformed vs reverted or reverted vs normal (Figure1a and Supplementary  Table 1 ). Only differential expression values greater or equal to two-folds and common to two independent experiments were regarded as significant.
The pattern of gene expression of reverted and normal cell lines was not identical, indicating that although overexpression of the GEF-DN effectively reverts many of the transcriptional modifications derived from Ras pathway activation, nevertheless a set of genes specifically up-or downregulated in reverted cells (i.e. genes whose expression was not modulated by K-ras transformation but was affected by the expression of the GEF-DN) was identified, suggesting that this cell line has a specific and distinct transcriptional profile.
Growth advantage of K-ras-transformed fibroblasts is reduced in low glucose availability As reported in the Introduction, many tumors and tumor cell lines display altered carbon metabolism. Thus, we decided to modulate carbon metabolism by growing normal, transformed and reverted cell lines with different initial glucose concentrations: normal (25 mM), low (1 mM) and in some experiments intermediate (5 mM). Cells were followed for at least 120 h, that is, from the moment of seeding to when they either reached confluence or started to grow in multi-strata or to die. All experiments reported in this and the following paragraphs refer to the above-mentioned experimental setup.
In a first set of experiments, duplication time, distribution of cells in different cell cycle phases and final cell density at the entrance of stationary phase were scored.
Both at normal and intermediate initial glucose concentration, the exponential phase of growth of normal fibroblasts only lasted about 48 h after inoculation. After this time, cell proliferation declined as shown by both cell counting and the increase in the fraction of G1 cells detected by DNA fluorescence-activated cell sorter (FACS) analysis (Figure 2a, b and d) . Under the same growth conditions, transformed cells maintained a steady-state growth for at least 72 h after inoculation and reached a much higher cell density than normal cells (Figure 2a, b and d) . Reverted cells reproducibly reached a final cell density intermediate between that of normal and transformed cells. Strikingly, the higher proliferation potential of transformed cells was lost upon growth in media supplemented with 1 mM initial glucose concentration as shown by the increase in G1 cells (Figure 2d ), the early decrease in the slope of the growth curve as well as by the reaching of a final cell density equal to that of normal and reverted cell lines (Figure 2c ). After glucose exhaustion, growth was supported by glutamine present in the medium (Baggetto, 1992) . Consistently, deprivation of both glucose and glutamine strongly reduced the growth and the survival of transformed cells and partially of normal and reverted cells (data not shown).
The duplication time of all three lines measured during the exponential phase of growth increased with decreasing initial glucose concentration. At 25 and 5 mM glucose, transformed cells have a slightly shorter duplication time than both normal and reverted cells. Although not statistically significant, such a difference was consistently observed in different experiments, but completely disappeared at 1 mM glucose (Figure 2c and d) .
In summary, these results indicate that in transformed cells the fraction of G1 cells remains constant at time points when it increases in normal and reverted cells, Carbon metabolism and transformation in mouse fibroblasts F Chiaradonna et al Figure 1 Comparative analysis of Ras-and GEF dominant-negative mutant (GEF-DN)-regulated genes using Affymetrix arrays. (a) The normal, transformed and reverted cell lines were plated at 3000 cell/cm 2 in media supplemented with 25 mM glucose and used for the RNA extraction after 48 h of growth. The differentially expressed genes were identified by using Affymetrix MG_U74Av2Array as described in Materials and methods. The number of genes showing at least a two-fold change in each of the two independent experiments is reported in the table. (b) The table shows some metabolic enzymes whose expression was differentially regulated in at least one pair-wise comparison. I, D and NC indicate increase, decrease and no change, respectively. Below are listed the genes considered for each pathway whose regulation was scored not change (NC) or in the Affymetrix arrays were not present (NP). Glycogen synthesis and utilization: (NC) UDP-glucose-pyrophosphorylase, glycogen synthase, branching enzyme, glycogen phosphorylase, phosphoglucomutase. (NP) Debranchhing enzyme (a1,4-a1,4 glucan transferase). Glucose transport: (NC) Slc2a4 (solute carrier family 2 facilitated glucose transporter), member 4, Slc2a1, Slc2a2, Slc2a5 and Slc2a8. Glycolysis part (I): (NC) Phosphofructokinase muscle, phosphofructokinase liver, aldolase 1, aldolase 2. Glycolysis part (II): (NC) Phosphoglycerate mutase 1, enolase 1 alpha non-neuron, pyruvate kinase 2 muscle. Gluconeogenesis: (NC) Glucose-6-phosphatase. (NP) Phosphenolpyruvate carboxykinase. Pyruvate utilization: (NC) Lactate dehydrogenase 2B, lactate dehydrogenase 3C. (NP) E3 (diidrolipoammide transacetylase). TCA phase (I): (NC) Citrate synthase, aconitase1, aconitase2, isocitrate dehydrogenase 2 (NADP þ ), mitochondrial isocitrate dehydrogenase 3 (NAD þ ) alpha, isocitrate dehydrogenase 3 (NAD þ ) beta, isocitrate dehydrogenase 3 (NAD þ ) gamma. (NP) a-oxoglutarate dehydrogenase complex, E1 (a-oxoglutarate decarboxylase), E2 (diidrolipoammide dehydrogenase, E3 (diidrolipoammide transacetylase). TCA phase (II): (NC) Succinate-CoA ligase GDP-forming alpha subunit, succinate-coenzyme A ligase GDP-forming beta subunit, succinate dehydrogenase complex subunit C, malate dehydrogenase, soluble. Pentose phosphate cycle: (NP) 6-Phospho-gluco-lactonase, phospho-gluco-lactonate, phosphopentose isomerase, transchetolase. Carbon metabolism and transformation in mouse fibroblasts F Chiaradonna et al indicating that expression of the GEF-DN reverts this aspect of the transformed phenotype. Moreover, the penetrance of the ras mutation is affected by glucose concentration initially present in the medium, as normal, transformed and reverted cell lines stop growing at the same time and at the same density in low glucose medium.
Glycolysis and mitochondrial respiration in normal, transformed and reverted cells Results obtained in the previous paragraph and the wide body of results in the literature prompted us to look closer at the pattern of expression of genes involved in energy metabolism. Results are reported in Figure 1b : expression of most genes encoding glycolytic enzymes and lactate dehydrogenase were upregulated in transformed cells. Conversely, expression of several genes involved in fatty acid biosynthesis was downregulated. Such a coordinated alteration of genes belonging to the same metabolic pathway is consistent with an alteration in glycolytic flux and ensuing remodeling of energy metabolism as a whole (see Thomas and Fell (1998) for an informative review on the issue of metabolic flux remodeling).
Glucose utilization, lactate production and respiratory capability of normal, transformed and reverted cells grown under normal and limiting glucose conditions were then assayed. Residual glucose and lactate secreted in the growth medium ( Figure 3 , panels a, b and c, d, respectively) were measured at different times during growth of normal, transformed and reverted cell lines in media supplemented with high (panels a and c) and low (panels b and d) initial glucose concentration. At high glucose concentration (25 mM), the large amount of initial glucose makes it difficult to obtain reliable glucose measurements at the first time points, but later points are in keeping with results obtained with 5 and 1 mM (data not shown). Our data show that on a per-cell basis transformed cells consume more glucose and produce more lactate than normal and reverted cells, as it is particularly evident in cells grown at low initial glucose concentration (Figure 3 , panels b and d).
A second set of experiments was designed to probe mitochondrial function by measuring endogenous oxygen consumption for normal, transformed and reverted cells collected after 24 and 96 h of growth at normal (25 mM) and low (1 mM) initial glucose concentrations. The oxygen consumption rates, determined using an oxygen electrode in the presence of saturating concentration of sodium pyruvate (1 mM) as a respiratory substrate for the cells collected at 24 and 96 h, were similar in all three cell types ( Figure Glucose shortage should lead not only to a reduced glycolytic flux but also to a decreased respiration rate because of pyruvate depletion (Messer et al., 2004) . Normally, cells are able to compensate for the glucose deprivation and the following ATP depletion, using other substrates normally present in culture medium, such as glutamine or/and malate to activate Carbon metabolism and transformation in mouse fibroblasts F Chiaradonna et al mitochondrial respiration (Baggetto, 1992) . Despite complete glucose depletion at 1 mM glucose, however, glucose consumption of transformed cells is insensitive to DNP, suggesting a derangement of mitochondrial function.
ROS production and cell death in normal, transformed and reverted cells
To further evaluate the relevance of glucose shortage on mitochondrial malfunctioning in transformed cells, we analysed whether growth under suboptimal glucose concentration altered reactive oxygen species (ROS) production, used as a readout of deranged mitochondria in normal, transformed and reverted cell lines grown in media supplemented with low and high initial glucose concentration. Cells from each line were loaded with the redox-sensitive probe 2 0 , 7 0 -dichlorofluorescein (DCFH), and ROS production was determined by FACS after 24, 72 and 96 h of growth. ROS production was detectable in transformed cells grown in media supplemented with both normal and low initial glucose concentration, as early as 24 h after plating, when no significant ROS production was detected in the normal cell line, and only a small amount of ROS was found in reverted cells. Enhanced ROS production in transformed vs normal and reverted cells is maximally evident at later time points (72 and 96 h). Data reported in Figure 4a show that growth in media supplemented with low glucose concentration induced ROS production compared to growth in normal growth conditions, as shown by the ratio between the ROS value observed in low glucose vs high glucose, which is maximally evident at 24 and 72 h after plating.
Strong production of ROS originates a metabolic oxidative stress (Lee et al., 1998b; Spitz et al., 2000) that may in turn activate the mitochondrial death cascade (Blackburn et al., 1999) . Microscopic analysis of the three cell lines cultured at 25 and 1 mM glucose was consistent with the hypothesis that transformed cells are undergoing extensive cell death when grown in media supplemented with low initial glucose concentration (Figure 4e ). This fact was further confirmed by scoring normal, transformed and reverted cells for other celldeath-related markers as described in Materials and methods. Phospholipid exposure monitored by binding of annexin V (Figure 4b ), the fraction of cells with a sub-G1 DNA content monitored by FACS analysis of propidium iodide (PI)-stained cells (Figure 4c ) and increase in caspase activity were found to be more sensitive to glucose limitation in transformed cells than in normal and reverted cells. The results were further confirmed by the ratio between the values observed in low glucose vs high glucose concentrations (tables in Figure 4b -d). Caspase-3 activity seemed to be the less discriminating parameter -among those tested -in distinguishing transformed from normal and reverted cell, possibly because the transcriptional upregulation of other apoptotic proteins, such as apoptotic-inducing factor or the transcriptional downregulation of some antiapoptotic genes such as Bcl2, observed in transformed cells (Figure 1c) , may induce DNA fragmentation in a caspase 3-independent manner.
In conclusion, results reported in this and the previous paragraph show a correlation among increased glucose utilization, decreased oxidative phosphorylation and cell death -monitored by different cell-death-related parameters -in transformed cells. These phenotypes are related to the expression of the oncogenic form of KRas as they are abolished by the expression of the GEF-DN protein, confirming the ability of this gene product to revert various aspects of the transformed phenotype. Carbon metabolism and transformation in mouse fibroblasts F Chiaradonna et al
The cell cycle network: transcriptome profiling and functional genomics The aberrant activation of the Ras proteins plays an important role in transformation and affects the regulation of components of the cell cycle machinery necessary for progression through the G1 phase and entrance into S phase (Takuwa and Takuwa, 2001 ).
Several genes involved in cell cycle control were either up-or downregulated in one or more of each pair-wise comparison: transformed vs normal, transformed vs reverted and reverted vs normal. Figure 5 represents a schematic map of the cell cycle regulatory network. The network is color-coded according to the change in expression of the mRNA encoding each protein in the transformed vs normal (Figure 5a ) and transformed vs reverted (panel b) pair-wise comparisons. In both panels, color-coding goes from red (upregulation) to green (downregulation), with yellow being no change and purple being not identified. Known transcriptional downstream targets of the Ras pathway, such as genes encoding c-Fos, cyclin D1 and p21 Cip1 (Albanese et al., 1995; Chen et al., 1997; Kivinen et al., 1999; Nheu et al., 2004) , were upregulated in the transformed cell line and downregulated in reverted cell lines, and have been scored as an internal control of reliability for our results. Other cell cycle-related genes showing the same behavior (i.e. upregulation in transformed cells and downregulation in reverted cells) include cyclin E, cyclin-dependent kinase (Cdk)4, E2F1, cyclin A and Cdk1. On the contrary Cdk2, Cdc25A and Cullin3 were found to be downregulated both in the transformed vs normal and transformed vs reverted comparison.
As noted above for the whole transcriptional profile, also the pattern of transcription of cell cycle-related genes in reverted cells was similar, although not identical to that of the normal parental cell line, indicating that while the reverted cells share a very similar phenotype with normal cells, they are not molecular phenocopies of the parent cell line. In particular, there is sustained transcriptional activation of E2F1, pRb, cyclin B and Cdk1 (compare Figure 5a and b) .
Microarray data were further validated by analysing the level of selected proteins on samples prepared from cells under the same growth conditions (Supplementary Figure S1) . Despite the major role played by posttranscriptional and post-translational modification in controlling cell cycle proteins, changes in expression at the RNA and protein level agreed remarkably well for Cdk4, p21 Cip1 , p27 Kip1 , cyclin D1, cyclin E and E2F1. The only relevant exception was Cdk2, whose average protein level was quite similar in all three cell lines, despite a reproducible large decrease at the mRNA level.
Sustained protein expression of cyclin D1, cyclin E and p21
Cip1 in transformed cells correlates with their enhanced growth ability at normal glucose Results reported in previous paragraphs (Figures 2 and  5 and Supplementary data) suggest that the enhanced proliferation potential of transformed cells grown in media supplemented with high initial glucose concentration may be strongly linked to a sustained activation of the cell cycle machinery involved in the G1 to S transition at later stages of the growth curve. It was therefore of interest to analyse the time course of the level of proteins involved in the G1 to S transition, in cells grown in media supplemented with either high or low initial glucose concentration. The G1 to S progression is governed by D-and E-type cyclin/Cdk complexes that are regulated by cyclin binding, by phosphorylation and by two families of Cdk inhibitors, the INK4 family, which acts specifically on Cdk4, and the KIP family, which comprises p21 Cip1 , p27
Kip1 and p57 Kip2 acting both on Cdk4 and Cdk2 (Arellano and Moreno, 1997; Cheng et al., 1999) . Besides, p21
Cip1 and p27 Kip1 also facilitate assembly and activation of cyclin D/Cdk4 in early G1 (Cheng et al., 1999; Chang and McCubrey, 2001) . Cip1 levels dropped as a function of growth time and were below detection at 96 h, in the transformed cells their steady-state level remained fairly high and constant during the 4 days of the experiment. In normal cells, a similar time-dependent decrease in protein level was observed also for cyclin A and Cdk4. Expression of these proteins was sustained in transformed cells, but, unlike the situation observed with cyclin D1 and p21
Cip1
, expression of the GEF-DN was not able to shut-down cyclin A and Cdk4 expression. Furthermore, also cyclin E level was higher and more constant in transformed cells compared to the normal and reverted cells. The pattern of expression of E2F1, Cdk2 and the Cdk inhibitor p27
Kip1 was very similar in the three cell lines. It has been reported that the function of p27 Kip1 inhibitor is also regulated by subcellular localization. In fact, cytoplasmic p27
Kip1 has been detected in about 40% of primary human breast cancer in conjunction with Akt activation and is associated with poor patient prognosis (Liang et al., 2002; Shin et al., 2002; Viglietto et al., 2002) . Thus, we performed immunofluorescence assay in the three cell lines at two different initial glucose concentrations (25 and 1 mM). The expression of oncogenic K-Ras induces, at both glucose concentrations, a diffuse staining for p27
Kip1 both in the nucleus and in the cytoplasm. Instead, in both normal and reverted cells, p27
Kip1 staining remains essentially restricted to the nuclei (Figure 7) .
The same time-course experiment was carried out on cells grown in media supplemented with low initial glucose concentration, as in this condition the proliferation potential of the transformed cells is strongly reduced (Figure 2c) . Results are reported in Figure 6b and panels a-c in Supplementary Figure S2 . In transformed cells, cyclin D1 levels slowly declined with time, whereas a more marked decrease was observed for p21 Cip1 . Cyclin A levels started to drop after 72 h of Carbon metabolism and transformation in mouse fibroblasts F Chiaradonna et al growth, eventually disappearing after 96 h. E2F1 levels followed a similar time-dependent declining pattern in all three lines.
Taken together, the results reported above indicate that sustained expression of cyclin D1, cyclin E and p21
Cip1 is a signature marker of the enhanced proliferation potential of transformed fibroblasts grown in media supplemented with high initial glucose concentration, as it is lost in reverted cells whose proliferation potential has reverted to essentially wild-type (normal) levels. On the contrary, sustained expression of Cdk4 and cyclin A is retained in reverted cells. In our experimental setup, level and localization of p27
Kip1 did not change significantly among normal, transformed and reverted cells, at both normal and low glucose concentrations. 
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Activity of G1 Cdks in normal and transformed cells
Cell cycle progression requires the assembly of specific complexes made by cyclin D1, cdk4, p21 Cip1 and p27 Kip1 in early G1 and cyclin E/cdk2 in late G1 (Arellano and Moreno, 1997; Cheng et al., 1999) . Both complexes participate in the phosphorylation of the Rb protein, a necessary step that allows disruption of the Rb/E2F complex (Dyson, 1998) , thus releasing free E2F that acts as a transcriptional activator of proliferation-related genes (Bracken et al., 2004) . Data reported in the previous paragraph suggested that both cyclin D1-and cyclin E-dependent kinase activities are required to express the enhanced proliferation potential of transformed fibroblasts. Cdk4 and Cdk2 complexes were thus immunoprecipitated from normal, transformed and reverted cells grown for 24, 48, 72 and 96 h in media supplemented with either high or low initial glucose concentration. Kinase activity and composition of each immunoprecipitated complex was then assayed (Figure 6 , Cdk4, panels c-d; Cdk2, panels e and f). Supplementary Figure S2 reports quantification of activity (average7s.d. of at least three independent experiments) of Cdk4 (panel d) and Cdk2 (panel e) immunocomplexes.
Regardless of initial glucose concentration, all cells displayed high Cdk4 activity at the initial time points (24 and 48 h after inoculation). In normal cells grown at normal initial glucose concentration, Cdk4 activity Figure 6 Time course of the expression of proteins involved in the G1 to S transition and cyclin-dependent kinase (Cdk)4 and Cdk2 activity in normal, transformed and reverted cell lines growing in media supplemented with different initial glucose concentration. For the protein expression analysis, the cells were grown in media containing either 25 mM glucose (a) or 1 mM glucose (b) and then were collected at appropriate time points and 40 mg of proteins from the total cellular extract were subjected to sodium dodecylsulfate (SDS)-polyacrylamide gel electrophoresis (SDS-PAGE) followed by Western blotting with appropriate antibodies. For the time course of Cdk4 and Cdk2 activity in normal, transformed and reverted cell lines, the three cell lines were grown in media containing either 25 mM glucose (c and e) or 1 mM glucose (d and f), along a 4-day time course. At appropriate time points, the cells were lysed and 500 mg of proteins were immunoprecipitated with either anti-Cdk4, anti-Cdk2 polyclonal antibodies or normal rabbit serum (CÀ) as indicated in Materials and methods. Kinase activity in the immunoprecipitates was analysed using GST-Rb or H1 as substrates for Cdk4 and Cdk2, respectively.
Carbon metabolism and transformation in mouse fibroblasts F Chiaradonna et al declined at later time points, whereas it remained essentially constant in transformed cells. Time-dependent sustaining of Cdk4 activity is dependent on both Ras activation and glucose availability, as it is lost in reverted cells (regardless of initial glucose concentration) as well as in transformed cells grown in media supplemented with low initial glucose concentration. In the latter condition, Cdk4 activity of transformed cells closely paralleled that found in normal and reverted cell lines, as reported in Figure 2c for the growth curve. The presence of both cyclin D1 and p21
Cip1 in the immunoprecipitated complex appears to be required in order to get full activity on the Rb substrate (compare cyclin D1 and p21
Cip1 levels in Cdk4 immunoprecipitates from normal and reverted cells to those from transformed cells).
In all three cell lines grown at high initial glucose concentration, activity of cyclin E/Cdk2 complex showed a minimum after 72 h of growth (Figure 6e) , and a partial recovery at the last examined time point (96 h). After 72 h of growth, cyclin E/Cdk2 activity from transformed cells was reproducibly higher. The timecourse pattern of cyclin E/Cdk2 activity from cells grown in media supplemented with low initial glucose concentrations was similar. However, in keeping with the decreased growth potential of transformed cells under these conditions and with results described above for Cdk4 activity, Cdk2 activity from transformed cell lines at the later time points (96 h) was not higher than activity assayed in normal and reverted cells.
Discussion
In this paper, we elucidate the role of oncogenic Ras activation, both in enhancing utilization of the glycolytic pathway in normoxic conditions and in the stimulation of ROS formation and of apoptosis promoted in transformed cells by glucose limitation. In addition, we show that oncogenic Ras activation modulates the expression of several genes and proteins involved in cell cycle and especially of those active in the G1 to S transition. Taken together, these findings support the notion that normal, transformed and reverted mouse fibroblasts, activated or downregulated in the Ras pathway, offer a very promising experimental system in which to study the circuits specific of transformed cells to better understand the road to cancer.
We could identify two major components in the altered metabolism of transformed cells: an accelerated glucose consumption and a (partially) uncoupled mitochondrial respiration, detected by biochemical measurements of glucose and lactic acid and oxygen consumption, respectively. The increased expression of several genes encoding glycolytic genes and lactate Kip1 . Normal, transformed and reverted cell lines were analysed by immunofluorescence staining for p27 Kip1 , after 72 h of growth in media supplemented with either 25 mM glucose or 1 mM glucose. DAPI (4 0 ,6-diamidine-2 0 -phenylindole dihydrochloride) staining of nuclei is shown in the right panels. In normal and reverted cells, p27
Kip1 is localized essentially in the nucleus. For transformed cells, the staining is more diffuse between the nucleus and the cytoplasm.
Carbon metabolism and transformation in mouse fibroblasts F Chiaradonna et al dehydrogenase is also consistent with the notion that these cells have a higher glycolytic flux. These findings agree with previous studies on cancer metabolism, showing that cancer cells preferentially employ glycolysis to fulfill their energetic requirements, releasing higher level of lactic acid in their environment as a result (Board et al., 1990; Dang and Semenza, 1999; Mazurek et al., 1999; Mazurek and Eigenbrodt, 2003; Ramanathan et al., 2005) . Such a preferential use of the glycolytic pathway is likely to confer selective advantage during hypoxic conditions occurring during the development of solid tumors. Indeed, it has been proposed by several authors that hypoxia itself is the inducing agent of the increased glycolysis (Harris, 2002; Gatenby and Gillies, 2004) . By using cells that are grown under normoxic conditions and the GEF-DN protein that specifically downregulates the Ras activation state, we show that metabolic rerouting does not take place in response to hypoxic conditions, but rather that it is a direct result of oncogenic activation of the Ras pathway. The transcription factor HIF1a, that is directly involved in the positive regulation of glycolytic enzymes in cooperation with Myc (Carmeliet et al., 1998; Osthus et al., 2000; Lee et al., 2004) , may be involved in such a Ras-dependent regulation as its mRNA is upregulated in transformed cells (Supplementary Figure S3) . While preferential use of the glycolytic pathway may give a selective advantage under hypoxic conditions, it does come at a price. Under conditions of glucose limitation, in fact, transformed cells continue to consume more glucose but are unable to upregulate mitochondrial activity. It has been shown that removal of glucose causes preferential cytotoxicity to human cancer cells compared to normal cells (Lee et al., 1998a; Spitz et al., 2000; Blum et al., 2005) . This response has been connected to the production of ROS such as superoxide and hydrogen peroxide during glucose deprivation, that is, to a metabolic oxidative stress (Blackburn et al., 1999; Ahmad et al., 2005) . As they grow at higher density under low glucose conditions, transformed cells produce much higher ROS levels than normal and reverted cells. As transformed cells are unable to respond to the uncoupler DNP, the failure of these cells to upregulate respiration is not simply owing to reduced pyruvate availability, but rather to a more severe defect in mitochondrial activity (Figure 3) . It is currently unknown how oncogenic K-Ras influences oxidative respiration, but several reports point to the ability of Akt and also c-Raf proteins, both targets of Ras, to modulate the function of the outer membrane voltage-dependent anion channel, principal component of the permeability transition pore of the mitochondrial membrane, and involved in exchange of metabolites for oxidative phosphorylation and in the control of apoptotic process (Vander Heiden et al., 2000; Shoshan-Barmatz and Gincel, 2003) . Consistently, we observed that in the transformed cells both Akt and Erk proteins are hyper-activated in high glucose, but especially for the Erks, such higher activity is completely lost in low glucose (Chiaradonna et al., 2005) .
Details regarding the molecular events linking ras activation to glucose availability remain to be elucidated. It is interesting to recall that the Ras pathway has long been known to be involved in nutrient sensing in lower eukaryotes (reviewed by Rolland et al., 2002) . Even in this organism, however, more than 20 years of research have been unable to uncover mechanistic details of this connection. Consistently with our results, it has recently been shown that in yeast an activated Ras2
Val19 protein is able to lock the mitochondrial respiration in a non-phosphorylating mode prone to generate ROS (Hlavata et al., 2003) . Moreover, mutants in the RAS2 gene have been isolated as suppressors of mutants in genes encoding subunits of the mitochondrial ATP synthase (Mabuchi et al., 2000) . Finally, it may be recalled that some reports of mitochondrial localization of Ras have been published, although their functional significance remains to be seen (Rebollo et al., 1999; Kocher et al., 2005) .
As transformed cells are characterized by the ability to continue to proliferate at higher density (Figure 2a and b), it was of interest to analyse the effects of Ras activation (and Ras downregulation) on the cell cycle machinery. The findings reported in this paper indicate that the Cdk4-cyclin D kinase activity is enhanced in transformed cell population. Such an activation is specifically shut-off by (i) downregulation of the Ras pathway through expression of the GEF-DN protein and (ii) by growth under low initial glucose concentration. Interestingly, terminal phenotypes of reverted cells and transformed cells grown under limiting conditions are quite different, since while a large fraction of transformed cells undergoes cell death, reverted cells do not.
In conclusion, we could show that the altered metabolic pattern of transformed cells is directly related to Ras activation itself and is not an adaptive response to hypoxia. While transformed cells are likely to survive better than normal cells under hypoxic conditions because of their preferential use of glycolysis, they show an acquired, transformationdependent fragility to glucose depletion. This acquired sensitivity to glucose shortage yields a decrease in proliferation ability derived by a combination of oxidative stress -resulting from mitochondrial malfunction and leading to apoptosis -and a reduced ability to enter S phase at higher cell density. Integration of experimental data such as those presented in this paper with genome-wide approaches able to give metabolite and flux profiling in mammalian cells (Hellerstein and Murphy, 2004 ) as well as computational approaches able to mine literature data and to aid in the definition of regulatory networks will eventually lead to a systemlevel understanding of the links among K-Ras-induced transformation, carbon and energy metabolism, cell cycle and cell death. As it has recently pointed out (Alberghina et al., 2004; Kitano, 2004) , such a knowledge appears a prerequisite for highlighting novel fragility points of cancer cells that could conveniently be used for the development of novel anticancer drugs and drug regimens.
Carbon metabolism and transformation in mouse fibroblasts F Chiaradonna et al
Materials and methods

Cell culture
Normal mouse fibroblasts (obtained from the ATCC, Manassas, VA, USA) and a K-Ras-transformed normal-derived cell line, 226.4.1 (Pulciani et al., 1985) , were routinely grown in Dulbecco's modified Eagle's medium (Invitrogen, Carlsbad, CA, USA) containing 10% newborn calf serum, 2 mM glutamine, 100 U/ml penicillin and 100 mg/ml streptomycin (normal growth medium), at 371C in a humidified atmosphere of 5% CO 2 . The reverted cell line, stably and constitutively expressing the dominant mutant Cdc25 W1056E (GEF-DN) (Bossu`et al., 2000) was maintained in normal growth medium supplemented with 0.7 mg/ml geneticin (G418; Sigma-Aldrich Inc., St Louis, MO, USA). Cells were passaged using trypsinethylenediaminetetraacetic acid (EDTA) (Invitrogen) and maintained in culture for 96 h before experimental manipulation. To verify the cell response to the glucose depletion, the cells were grown in medium without glucose and sodium pyruvate (Invitrogen) supplemented with the appropriate concentration of glucose (25, 5 and 1 mM).
Measurement of D-glucose and L-lactic acid
The cells were plated into six-well flat-bottomed culture plates at the density of 3000 cells/cm 2 in normal growth medium (25 mM glucose). At 18 h after the seeding, the cells were washed two folds with phosphate-buffered saline (PBS) and incubated in media with different glucose concentrations (25, 5 and 1 mM glucose). The cells and the culture supernatants were harvested at different time points (8, 24, 30, 48, 54, 72, 78, 96 h from the plating). To measure cell proliferation, harvested cells were counted by Coulter Counter. Duplication time was calculated by curve fitting of the data plotting the number of counted cells vs time. Concentrations of D-glucose and L-lactic acid in the supernatants were determined by using the Dglucose and L-Lactic acid UV-method kits (r-biopharmRoche, Basel, CH), respectively.
Polarographic analysis of intact cells
Cells plated and cultured as described before were collected in culture medium after the treatment with trypsin, washed twice with PBS and placed at E1 Â 10 6 cells/ml in 2 ml of PBS supplemented with 10% fetal calf serum at 251C in a Clark's type oxygraph chamber.
The basal rate of oxygen consumption was calculated by recording the trace for at least 5 min, then 1 mM sodium pyruvate was added and the trace recorded for at least 5 min, then DNP was added to the chamber to a final concentration of 100 mM, and maximal uncoupled rate of respiration was recorded for additional 5 min or more.
Gel electrophoresis and immunoblotting
Cells were lysed in a buffer containing 150 mM NaCl, 0.5% NP-40, 1% glycerol, 50 mM HEPES (pH 7.5) and 5 mM ethyleneglycol tetracetate (EGTA), plus a mixture of protease inhibitors (1 mg/ml leupeptin, 1 mg/ml aprotinin, 1 mg/ml pepstatin, 1 mM phenylmethylsulfonyl (PMSF) and 50 mM NaF). After incubation for 20 min on ice, the extracts were centrifuged at 13 200 r.p.m. (Eppendorf) for 20 min. Protein concentration of supernatant was measured by the Bradford procedure (Bio-Rad Laboratories, Richmond, CA, USA), using bovine serum albumin as a standard. These cellular extracts were electrophoresed in sodium dodecylsulfate (SDS)-polyacrylamide gels essentially as described previously (Laemmli, 1970) . After electrophoresis, the proteins were transferred to nitrocellulose membrane by electroblotting. The membranes were pre-incubated in Tris-buffered saline (TBS) (20 mM Tris-HCl (pH 7.5), 150 mM NaCl)-0.01% Tween 20-5% defatted milk powder for 30 min at room temperature and then incubated in TBS-0.01% Tween 20-5% defatted milk powder containing the appropriate antibodies for 2 h at room temperature. The antibodies used were monoclonal or polyclonal antibodies against cyclin E, cyclin A, cyclin D1, Cdk4, Cdk2, p21
Cip1 and p27 Kip1 (Santa Cruz Inc., Santa Cruz, CA, USA). After two washings (10 min each) in TBS-0.01% Tween 20, the membranes were incubated with a peroxidase-coupled secondary antibody (Amersham, Otelfingen, CH) for 30 min at room temperature. After incubation, the membranes were washed twice in TBS-0.01% Tween 20 and once in TBS. The reaction was visualized with ECL (Amersham) followed by exposure to an X-ray film.
Immunoprecipitation and kinase assay Immunoprecipitation/kinase assays were performed using a modification of the method described by Jinno et al. (1999) . In brief, 500 mg protein extracts, obtained by lysing 5 Â 10 6 cells in ice-cold immunoprecipitation buffer consisting of 50 mM HEPES (pH 7.5), 150 mM NaCl, 1 mM EDTA, 2.5 mM EGTA, 1 mM dithiothreitol (DTT), 0.1% Tween-20, 10% glycerol, 1 mM PMSF, 4 mg/ml each of leupeptin, pepstatin, and aprotinin, 0.1 M NaF, 2 mM sodium orthovanadate respectively, were pre-cleared with 40 ml of protein A-agarose beads on a rotator for 30 min at 41C and the agarose beads were pelleted by centrifugation for 5 min at 1500 r.p.m. (Eppendorf). The supernatant was then mixed with antibody to Cdk4 (Santa Cruz) or Cdk2 (Santa Cruz) or normal rabbit serum. The mixture was rotated at 41C for 16 h and then 30 ml of protein A-agarose beads were added to supernatant and rotated at 41C for 1 h. The agarose beads were recovered by centrifugation, washed twice with lysis buffer and once in 1 Â kinase buffer and then incubated in kinase reaction buffer (50 mM HEPES (pH 7.5), 1 mM EGTA, 10 mM KCl, 10 mM MgCl 2 , 1 mM DTT and 10 mM ATP) containing 1 mg of recombinant GST-Rb protein (Santa Cruz) for Cdk4 immunoprecipitates and 1 mg of recombinant histone H1 (Santa Cruz) for Cdk2 immunoprecipitates. The reaction mixture was left for 30 min at 301C and was neutralized by the addition of 25 ml of 2 Â SDS protein loading buffer. The reaction products were divided in equal amounts and electrophoresed on two different 12% SDS-polyacrylamide gels. Phosphorylated GST-Rb or histone H1 was analysed directly by autoradiography. Other gel was transferred to nitrocellulose membrane filters and used to immunodetect the immunoprecipitated proteins. One-tenth of reaction products were electrophoresed on separate 12% SDS-polyacrylamide gels and then stained with Coomassie Blue to normalize the amount of added substrates (GST-Rb or H1 histone) to the reactions. Image acquisition for protein quantification.
Images were scanned at a minimum resolution of 300 d.p.i. The protein levels were quantified by densitometry of raw TIFF images using the NIH Image-based software Scion Image (Scion Corporation, Frederick, MD, USA). The densitometry values obtained for each protein were then normalized by using the densitometry values of the corresponding vinculin.
Cell cycle analysis
Cell cycle stages were determined using fluorescence-activated cell sorter (FACScan; Becton-Dickinson, Franklin Lakes, NJ, USA). Briefly, cells (10 6 cells per analysis) were washed with PBS, fixed in cold 70% ethanol and then the samples were resuspended in PBS containing PI (50 mg/ml) and RNAse A (400 mg/ml). The cell cycle distribution was determined by DNA content. Data were analysed using Cell Quest software (BD Bioscience, Bredford, MA, USA).
Analysis of apoptosis
Apoptotic cells were detected by flow cytometry according to published procedures (Darzynkiewics, 1992) . Basically, cells were washed with PBS, fixed in cold 70% ethanol and then stained with PI (50 mg/ml) while treating with RNAse (400 mg/ ml). Quantitative analysis of sub-G1 cells was carried out in an FACS (FACScan; Becton-Dickinson) using the Cell Quest software (BD Bioscience). Annexin V was used as another indicator of cell apoptosis. After washing with binding buffer (10 mM HEPES (pH 7.5), 150 mM NaCl, 3.6 mM CaCl 2 , 1 mM MgCl 2 , 5 mM KCl), 5 Â 10 5 cells were resuspended in 50 ml annexin V-FITC conjugate (Sigma) diluted 1:50 in binding buffer and incubated for 1 h in the dark at room temperature. After washing once with binding buffer, cells were resuspended in 500 ml PBS and 1 ml of a 50 mg/ml PI solution was added before analysis with FACScan, to distinguish cells that had lost membrane integrity.
Quantitative measurement of caspase-3 activity was achieved using a chromogenic substrate provided with the CaspACEt Assay System, Colorimetric (Promega, Madison, WI, USA). The reactions were performed using 50 mg of whole-cell lysates. Cells treated with 100 nM staurosporine for 24 h were used as positive control.
Determination of intracellular ROS Intracellular accumulation of H 2 O 2 and O 2
À were determined with the probe 2 0 ,7 0 -dichlorodihydrofluorescein di-acetate (Molecular Probes Inc., Eugene, OR, USA). The cells were incubated for 30 min with H 2 DCFDA 5 mM, harvested at 371C using trypsin, resuspended using PBS with NCS (Invitrogen Inc., Carlsbad, CA, USA) 10% and analysed by FACS (FACScan; Becton-Dickinson), using the Cell Quest software (BD Bioscience). The percentage of ROS-producing cells was calculated for each sample and corrected for autofluorescence obtained from samples of unlabeled cells. Data analysis was performed with WinMDI software.
RNA preparation and affymetrix analysis
For the Affymetrix Gene Chip screening, the three cell lines were plated 3000 cells/cm 2 in high glucose. After 2 days, the cells were detached to prepare the mRNAs and the relative cRNAs. Total RNA was prepared using Trizol reagent (GIBCO-BRL, Gran Island, NY, USA), following the manufacturers protocol. Double-strand cDNA was synthesized from total RNA using Superscritptt cDNA Synthesis kit (Life Technologies, Carlsbad, CA, USA) and the oligo T-7-(dT)24 primer that contained a T-7 RNA polymerase site. cDNA was in vitro transcribed using the T7 BioArray High Yield RNA Transcript Labeling Kit (Enzo Biochem, Farming Dale, NY, USA) to produce biotinylated cRNA. Labeled cRNA was isolated using an RNeasy Mini Kit column (Qiagen Inc., Valencia, CA, USA). Purified cRNA was fragmented to 200-300 mer cRNA using a fragmentation buffer as suggested by Affymetrix protocol. Housekeeping controls a-actin and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) genes served as endogenous controls and were added to the sample to monitor the quality of the target.
Biotin-labeled cRNAs were hybridized to an MG_U74Av2 Affymetrix Gene Chip. Hybridization experiments were repeated twice using independent cRNA probes synthesized with RNA from two independent sets of cells. Data presented in this work represents the average of both experiments.
Raw data were analysed using Affymetrix Gene Chip software Mass 5.1. Fold change was calculated using the Affymetrix Gene Chip software with a Comparison Analysis where two samples, hybridized to two Gene Chip probe arrays of the same type, are compared with different types of algorithm against each other in order to detect and quantify changes in gene expression. Results were further elaborated through replica and statistical methods using various software. Microarray methods are described in more detail in Supplementary Data.
